Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$1.51 USD
+0.04 (2.72%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $1.47 -0.04 (-2.65%) 7:28 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.42 | 9.52% |
Earnings Summary
For their last quarter, Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.64 per share. This reflects a positive earnings surprise of 37.50%. Look out for BRNS's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 32.26%.
Earnings History
Price & Consensus
Zacks News for BRNS
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
BRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services